Hening Lin
- Geriatrics and Gerontology top 0.02%
- Sirtuins and Resveratrol in Medicine 63
- Physiology top 0.05%
- Calcium signaling and nucleotide metabolism 39
- Molecular Biology top 1%
- Ubiquitin and proteasome pathways 15
- Histone Deacetylase Inhibitors Research 15
- RNA and protein synthesis mechanisms 14
- Oncology top 1%
- PARP inhibition in cancer therapy 23
- Epidemiology top 1%
- Autophagy in Disease and Therapy 33
-
- Metalloenzymes and iron-sulfur proteins 13
- Journals
- Journal of the American Chemical Society (21 papers)ACS Chemical Biology (20 papers)Proceedings of the National Academy of Sciences (16 papers)
- Partner nations
- United StatesChinaHong Kong
In The Last Decade
Hening Lin
177 papers receiving 10.1k citations
Hit Papers
Peers
Comparison fields: 5 of 133
- Geriatrics and Gerontology 3.3k
- Physiology 1.4k
- Molecular Biology 5.8k
- Oncology 1.9k
- Epidemiology 2.0k
Countries citing papers authored by Hening Lin
This map shows the geographic impact of Hening Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hening Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hening Lin more than expected).
Fields of papers citing papers by Hening Lin
This network shows the impact of papers produced by Hening Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hening Lin. The network helps show where Hening Lin may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Hening Lin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2024 | 0 | |
| 3 | 2024 | 1 | |
| 4 | 2023 | 16 | |
| 5 | 2022 | 21 | |
| 6 | 2022 | 72 | |
| 7 | 2021 | 56 | |
| 8 | 2021 | 18 | |
| 9 | 2021 | 9 | |
| 10 | 2021 | 24 | |
| 11 | 2020 | 77 | |
| 12 | 2020 | 62 | |
| 13 | 2019 | 132 | |
| 14 | 2018 | 53 | |
| 15 | 2016 | 283 | |
| 16 | 2016 | 182 | |
| 17 | 2006 | 246 | |
| 18 | 2004 | 142 | |
| 19 | 2003 | 160 | |
| 20 | 2002 | 67 |
About Hening Lin
Hening Lin is a scholar working on Geriatrics and Gerontology, Physiology and Oncology, having authored 179 papers that have together received 10.2k indexed citations. Recurring topics across this work include Sirtuins and Resveratrol in Medicine (63 papers), Calcium signaling and nucleotide metabolism (39 papers), Autophagy in Disease and Therapy (33 papers), PARP inhibition in cancer therapy (23 papers), Ubiquitin and proteasome pathways (15 papers), Histone Deacetylase Inhibitors Research (15 papers), RNA and protein synthesis mechanisms (14 papers) and Metalloenzymes and iron-sulfur proteins (13 papers). The work is most often cited by research in Geriatrics and Gerontology (3.3k citations), Physiology (1.4k citations) and Molecular Biology (5.8k citations). Hening Lin has collaborated with scholars based in United States, China and Hong Kong. Frequent co-authors include Bin He, Hui Jing, Jintang Du, Xiaoyu Zhang, Quan Hao, Hong Jiang, Xiaoyang Su, Virginia W. Cornish, Michael A. Fischbach and David R. Liu. Their work appears in journals such as Journal of the American Chemical Society, ACS Chemical Biology, Proceedings of the National Academy of Sciences, Biochemistry and Journal of Biological Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.